Verastem Inc (VSTM)

Verastem Inc (VSTM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $781M; returns 1 day -0.2%, 1 week +16.1%, 1 year +28.6%.

Verastem, Inc. (VSTM), also known as Verastem Oncology, is a biopharmaceutical company committed to developing and commercializing new medicines to improve the lives of patients diagnosed with RAS/MAPK pathway-driven cancers. Verastem focuses on developing small molecule drugs that inhibit critical signaling pathways in cancer to promote cancer cell survival and tumor growth.

Groups VSTM belongs to

• Biotechnology
• Oncology
• Healthcare
• Biopharmaceutical
• Cancer Therapeutics
• Commercial Stage Biotech
• Ovarian Cancer
• Pharmaceuticals
• Commercial Stage
• Life Sciences

VSTM financial model: income statement, cash flow and balance sheet